Cargando…

Immunologic and Virologic Outcomes of Obese and Nonobese Incarcerated Adults on Antiretroviral Therapy for HIV Infection

BACKGROUND: Obesity is common among patients with HIV. The objective of this study was to characterize response to antiretroviral therapy (ART) in a cohort of obese incarcerated adults compared to a nonobese cohort. METHODS: A retrospective matched cohort study was conducted in an HIV telemedicine c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bunnell, Kristen L., Aldossari, Arwa, Perkins, Connor, Schriever, Christopher, Chiampas, Thomas D., Young, Jeremy D., Patel, Mahesh C., Badowski, Melissa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748539/ https://www.ncbi.nlm.nih.gov/pubmed/29357770 http://dx.doi.org/10.1177/2325957417752261

Ejemplares similares

941. Incarcerated patients living with HIV: Atherosclerotic cardiovascular disease risk and management
por: Michienzi, Sarah M, et al.
Publicado: (2020)

1313. Complementary Effects of Medical Follow-up and Virologic Suppression for Reincarcerated Inmates Living with HIV
por: Badowski, Melissa E, et al.
Publicado: (2019)

Evaluation of the occurrence and type of antiretroviral and opportunistic infection medication errors within the inpatient setting
por: Chiampas, Thomas D., et al.
Publicado: (2015)

Impact of an HIV-trained clinical pharmacist intervention on error rates of antiretroviral and opportunistic infection medications in the inpatient setting
por: Chiampas, Thomas D., et al.
Publicado: (2019)

Clinical, Immunological, and Virological SARS-CoV-2 Phenotypes in Obese and Nonobese Military Health System Beneficiaries
por: Epsi, Nusrat J, et al.
Publicado: (2021)

Weight Gain in Incarcerated Individuals Living With HIV After Switching to Integrase Strand Inhibitor-Based Therapy
por: Goldberg, Rachel N., et al.
Publicado: (2021)

1309. Effects of a Pharmacist-Driven Antiretroviral Stewardship and Transitions of Care Service in Persons Living with HIV/AIDS
por: Brizzi, Marisa B, et al.
Publicado: (2019)

Impact of Pharmacist-Driven Antiretroviral Stewardship and Transitions of Care Interventions on Persons With Human Immunodeficiency Virus
por: Brizzi, Marisa B, et al.
Publicado: (2020)

Association Between Estimated Pharmacokinetic/Pharmacodynamic Predictions of Efficacy and Observed Clinical Outcomes in Obese and Nonobese Patients With Enterobacteriaceae Bloodstream Infections
por: Santibañez, Melissa, et al.
Publicado: (2019)

Virologic, immunologic and clinical response of infants to antiretroviral therapy in Kampala, Uganda
por: Tukei, Vincent J, et al.
Publicado: (2013)

Clinical, immunological, and virological outcomes of pediatric antiretroviral therapy in central China
por: Zheng, Junwen, et al.
Publicado: (2014)

Virologic, clinical and immunologic responses following failure of first-line antiretroviral therapy in Haiti
por: Charles, Macarthur, et al.
Publicado: (2012)

Immunological failure despite virological suppression in HIV seropositive individuals on antiretroviral therapy
por: Prabhakar, B., et al.
Publicado: (2011)

Retrospective Review of Virologic and Immunologic Response in Treatment-Experienced Patients on Third-Line HIV Therapy in Lusaka, Zambia
por: Zulu, Paul Msanzya, et al.
Publicado: (2021)

Pharmacy refill data can be used to predict virologic failure for patients on antiretroviral therapy in Brazil
por: Martin, David, et al.
Publicado: (2017)

Long-term clinical, immunological and virological outcomes of patients on antiretroviral therapy in southern Myanmar
por: Bermúdez-Aza, Elkin Hernán, et al.
Publicado: (2018)

Virology and Immunology of Bats
por: Schountz, Tony
Publicado: (2013)

Virological outcomes of antiretroviral therapy in Zomba central prison, Malawi; a cross-sectional study
por: Mpawa, Happy, et al.
Publicado: (2017)

Virological failure and development of new resistance mutations according to CD4 count at combination antiretroviral therapy initiation
por: Jose, S, et al.
Publicado: (2015)

Association of Age with Mortality and Virological and Immunological Response to Antiretroviral Therapy in Rural South African Adults
por: Mutevedzi, Portia C., et al.
Publicado: (2011)

Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy
por: Melku, Mulugeta, et al.
Publicado: (2020)

The vulnerability of men to virologic failure during antiretroviral therapy in a public routine clinic in Burkina Faso
por: Penot, Pauline, et al.
Publicado: (2014)

Factors Affecting Virological Outcome When First-Line Antiretroviral Therapy Is Reintroduced After Unplanned Interruption
por: Maria, Suzy, et al.
Publicado: (2020)

Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months’ antiretroviral therapy experience in Cameroon
por: Aghokeng, Avelin F, et al.
Publicado: (2013)

Virological and immunological correlates of HIV posttreatment control after temporal antiretroviral therapy during acute HIV infection
por: van Paassen, Pien M., et al.
Publicado: (2023)

Immunologic status and virologic outcomes in repeat pregnancies to HIV-positive women not on antiretroviral therapy at conception: a case for lifelong antiretroviral therapy?
por: French, Clare E., et al.
Publicado: (2014)

Virologic versus immunologic monitoring and the rate of accumulated genotypic resistance to first-line antiretroviral drugs in Uganda
por: Reynolds, Steven J, et al.
Publicado: (2012)

Adherence to contemporary antiretroviral treatment regimens and impact on immunological and virologic outcomes in a US healthcare system
por: T. Tchakoute, Christophe, et al.
Publicado: (2022)

State Laws on Substance Use Treatment for Incarcerated Pregnant and Postpartum People
por: Steely Smith, Mollee K, et al.
Publicado: (2023)

Virological failure rates and HIV-1 drug resistance patterns in patients on first-line antiretroviral treatment in semirural and rural Gabon
por: Liégeois, Florian, et al.
Publicado: (2012)

Virological outcome among HIV-1 infected patients on first-line antiretroviral treatment in semi-rural HIV clinics in Togo
por: Konou, Abla A., et al.
Publicado: (2015)

Gender differences in clinical, immunological, and virological outcomes in highly active antiretroviral-treated HIV–HCV coinfected patients
por: Emery, Joel, et al.
Publicado: (2010)

Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
por: Bunupuradah, Torsak, et al.
Publicado: (2011)

The Clinical Impact of Continuing to Prescribe Antiretroviral Therapy in Patients with Advanced AIDS Who Manifest No Virologic or Immunologic Benefit
por: Wohl, David A., et al.
Publicado: (2013)

Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China
por: Liao, Lingjie, et al.
Publicado: (2013)

The Virological and Immunological Characteristics of the HIV-1-Infected Population in Brazil: From Initial Diagnosis to Impact of Antiretroviral Use
por: Diaz, Ricardo Sobhie, et al.
Publicado: (2015)

Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients
por: Portocarrero Nuñez, Julian Alexander, et al.
Publicado: (2018)

Immunological and virological discordance among people living with HIV on highly active antiretroviral therapy in Tigray, Northern Ethiopia
por: Hailu, Genet Gebrehiwet, et al.
Publicado: (2021)

Virological and Immunological Antiretroviral Treatment Failure and Predictors Among HIV Positive Adult and Adolescent Clients in Southeast Ethiopia
por: Mamo, Ayele, et al.
Publicado: (2022)

Immunological factors associated with discordant virological response postcombination antiretroviral therapy in pediatric human immunodeficiency virus infection
por: Singh, Ravinder, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8lg1ntu8nb60b32uuglir3fhf1